Jiyang Yu
- Molecular Biology top 5%
- RNA modifications and cancer 9
- Single-cell and spatial transcriptomics 8
- Epigenetics and DNA Methylation 6
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 5%
- CAR-T cell therapy research 6
- Cell Biology top 5%
-
- Acute Lymphoblastic Leukemia research 8
- Co-authors
- Yuxin LiQingfei PanHong Joo KimZemin YangJames MessingPeiguo YangJ. Paul TaylorErik Martin
- Partner nations
- United StatesChinaItaly
In The Last Decade
Jiyang Yu
69 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 1.8k
- Immunology 491
- Cancer Research 305
- Oncology 511
- Cell Biology 263
Countries citing papers authored by Jiyang Yu
This map shows the geographic impact of Jiyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyang Yu more than expected).
Fields of papers citing papers by Jiyang Yu
This network shows the impact of papers produced by Jiyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyang Yu. The network helps show where Jiyang Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiyang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 10 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 37 | |
| 15 | 2021 | 95 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 7 | |
| 18 | 2019 | 53 | |
| 19 | 2017 | 71 | |
| 20 | 2015 | 9 |
About Jiyang Yu
Jiyang Yu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 74 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Single-cell and spatial transcriptomics (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Molecular Biology (1.8k citations), Immunology (491 citations) and Cancer Research (305 citations). Jiyang Yu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Yuxin Li, Qingfei Pan, Hong Joo Kim, Zemin Yang, James Messing, Peiguo Yang, J. Paul Taylor, Erik Martin, Regina‐Maria Kolaitis and Jinjun Wu. Their work appears in journals such as Blood, Cancer Research, Nature Communications, Leukemia and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.